Kenneth Dickstein
Stavanger University Hospital · 132 works · 23,047 citations · h-index 42
Top works
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
- ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
- ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
- Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
- Aliskiren, ALTITUDE, and the Implications for ATMOSPHERE
- Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure.
- Losartan in Heart Failure
- Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure
- Recommendations on Pre-Hospital & Early Hospital Management of Acute Heart Failure: A Consensus Paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine
- Corrigendum to: ‘ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012’ [Eur J Heart Fail 2012;14: 803–869]
- Self-Care Management of Heart Failure: Practical Recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology
- Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure
- ESC Guidelines for the Diagnosis And Treatment of Acute And Chronic Heart Failure 2008
- Direct Renin Inhibition in Addition to or as an Alternative to Angiotensin Converting Enzyme Inhibition in Patients with Chronic Systolic Heart Failure: Rationale and Design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) Study
- Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure
- Corrigendum to: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) [Eur Heart J 2008;29:2388-2442]
- Left Bundle Branch Block as a Risk Factor for Progression to Heart Failure
- Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF)
- Hemodynamic and neurohumoral effects of the angiotensin II antagonist losartan in patients with heart failure.
- Corrigendum to: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012’[Eur Heart J 2012;33:1787–1847, doi:10.1093/eurheartj/ehs104